Charleston, SC -- (SBWIRE) -- 01/22/2014 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks, MENTOR CAPITAL, INC.(OTCMKTS:MNTR), Bayside Corp(OTCMKTS:BYSD), International Stem Cell Corp(OTCMKTS:ISCO), Elite Pharmaceuticals Inc(OTCBB:ELTP)
MENTOR CAPITAL, INC.(OTCMKTS:MNTR) closed latest trading day at $2.20, up +15.79%, on volume of over 491,490.00 shares. The stock went up 890.99% in the last 5 days. Its average trading volume is 32,948.00 shares. In the time frame of the last one month, the share-price has surged almost 566.87%. Its market capitalization was $6.19 million. Mentor Capital, Inc. is a private equity firm specializing in acquisitions. The firm provides passive equity funding and liquidity to smaller companies and owners.
What was the Moving Force behind MNTR On Bullish Run? Read This Research Report on MNTR
With the latest decline of -25.00%, Bayside Corp(OTCMKTS:BYSD) now has YTD performance 466.67% which for the week is positive at 155%. The total number of shares traded on the latest trading day was about 35.58 million shares, and changed hands at price range of $0.01 to $0.01 apiece. The company ended previous trading at $0.01. Bayside Corporation operates as an energy exploration, development, and production company.
Has BYSD Found The Bottom And Ready To Gain Momentum? Find Out Here
International Stem Cell Corp(OTCMKTS:ISCO) traded $0.215 in the latest trading session It captured $32.08 million in market value. The total number of shares traded on the latest trading day was about 2.78 million shares. The day started out with an opening price of $0.22 and changed hands at price range of $0.21 to $0.23 apiece. International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally.
Can Investors Bet on ISCO after this News update? Find out in this Research Report
Elite Pharmaceuticals Inc(OTCBB:ELTP) ended previous trading at $0.24, gaining +4.68%.The total number of shares traded on the latest trading day was about 4.77 million shares. In the last 5 days it showed a recovery of 40.73% and on its one month graph, shares are 105% up. The stock has a 52-week high price of $0.27 and its 52-week low was recorded at $0.06. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, principally engages in the research, development, and licensing of proprietary controlled-release drug delivery systems and products.
Will ELTP Continue To Move Higher? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)